Zydus Lifesciences share news, announcements and annual reports
NSE: ZYDUSLIFEBSE: 532321Pharmaceuticals & BiotechnologyMid Cap
Zydus Lifesciences Limited · Formerly Cadila Healthcare · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2000
Last close ₹1,184.40up ₹8.90 (0.76%)BSE ₹1,186.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,175.50.
29 Oct: open ₹1,175.50, high ₹1,187.80, low ₹1,170.50
52-week range of traded prices to 29 Oct 2026
₹835.50Low, 2 Apr 2026₹1,232.10High, 29 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,18,144 Cr114th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.18
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹535 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 23.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.36
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹535 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,55,85055.6% delivered
Zydus Lifesciences has 1,761 announcements on record, routine notices left out; 11 in the 30 days to 30 Oct 2026, the latest on 24 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Zydus Lifesciences quarterly results
Nov4Wed
The board meets on 4 Nov 2026 to consider financial results
Notice filed 19 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Zydus Lifesciences annual reports, presentations and earnings calls
The company's own documents, latest first.Zydus Lifesciences financials, year by year
Annual reports17
- Annual report, year to Mar 202610 Jul 2026
- Annual report, year to Mar 202516 Jul 2025
- Annual report, year to Mar 202411 Jul 2024
- Annual report, year to Mar 202314 Jul 2023, a zip file
- Annual report, year to Mar 202215 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202117 Jul 2021, a zip file
- Annual report, year to Mar 202031 Jul 2020, a zip file
- Annual report, year to Mar 201913 Jul 2019, a zip file
- Annual report, year to Mar 201814 Aug 2018, a zip file
- Annual report, year to Mar 201717 Aug 2017, a zip file
- Annual report, year to Mar 20165 Aug 2016, a zip file
- Annual report, year to Mar 201516 Jul 2015, a zip file
- Annual report, year to Mar 20142 Jul 2014, a zip file
- Annual report, year to Mar 201316 Sep 2013, a zip file
- Annual report, year to Mar 201211 Jul 2012, a zip file
- Annual report, year to Mar 201114 Jul 2011, a zip file
- Annual report, year to Mar 20108 Sep 2010, a zip file
Investor presentations57
- Investor Presentation23 Aug 2026
- Investor Presentation11 Aug 2026
- Investor Presentation19 May 2026
- Investor Presentation9 Feb 2026
- Investor Presentation25 Nov 2025
52 earlier presentations
- Investor Presentation6 Nov 2025
- Investor Presentation12 Aug 2025
- Investor Presentation24 Jun 2025
- Investor Presentation20 May 2025
- Investor Presentation11 Mar 2025
- Investor Presentation5 Feb 2025
- Investor Presentation12 Nov 2024
- Investor Presentation27 Aug 2024
- Investor Presentation9 Aug 2024
- Investor Presentation17 May 2024
- Investor Presentation9 Feb 2024
- Investor Presentation7 Nov 2023
- Investor Presentation17 Sep 2023
- Investor Presentation11 Aug 2023
- Investor Presentation18 May 2023
- Investor Presentation3 Feb 2023
- Investor Presentation on the unaudited financial results for thequarter / half year ended on September 30, 202211 Nov 2022
- Investor Presentation10 Aug 2022
- Investor Presentation20 May 2022
- Investor Presentation3 Feb 2022
- Investor Presentation29 Oct 2021
- Update on Investor Presentation11 Aug 2021
- Investor Presentation11 Aug 2021
- Investor Presentation12 Jan 2021
- Revised Investor Presentation26 Aug 2020
- Investor Presentation26 Aug 2020
- Investor Presentation to be made to select investors on Wednesday February 12, 2020 at Mumbai in IIFL Investor Conference.11 Feb 2020
- Investor Presentation17 Jun 2019
- Investor Presentations Revised7 Jan 2019
- Investor Presentation7 Jan 2019
- Investor Presentation16 Jun 2018, a zip file
- Investor Presentation1 Apr 2018, a zip file
- Investor Presentation15 Nov 2017, a zip file
- Investor Presentation20 Sep 2017, a zip file
- Investor Presentation14 Jun 2017, a zip file
- Regarding Investor Presentation.22 Mar 2017, a zip file
- Investor Presentation21 Feb 2017, a zip file
- Investor Presentation9 Jan 2017, a zip file
- Intimation for Investors' Presentation.30 May 2016, a zip file
- Investor Presentation May 2015.28 May 2015, a zip file
- Investor Presentation February 2015.23 Feb 2015, a zip file
- Investor Presentation.7 Oct 2014, a zip file
- Investor Presentation.14 Aug 2014, a zip file
- Presentation to the Investors conference during August 18, 2014 to August 20, 201414 Aug 2014, a zip file
- Investor Presentation November, 20128 Nov 2012, a zip file
- Investors Presentation proposed to be made to the investors in the month of September, 2012 for the information to the members and investors at large.13 Sep 2012, a zip file
- Investors presentation June 2012.5 Jun 2012, a zip file
- 'Investor's Presentation' which the Company's Chairman and Managing Director will make in separate one-to-one meetings with selective investors on March 14, 2012, for the information to the members and investors at large.14 Mar 2012, a zip file
- Investors Presentation August, 2011 for the information to the members and investors at large.5 Aug 2011, a zip file
- Investors presentation June 2011.6 Jul 2011, a zip file
- Presentation proposed to be made to the Investors on February 17, 2011.17 Feb 2011, a zip file
- Presentation proposed to be made by the Company Chairman and Managing Director Mr. Pankaj R. Patel to the Investors.15 May 2010, a zip file
Earnings calls46
- Transcript of the 31st Annual General Meeting1 Sep 2026
- Transcript18 Aug 2026
- Link of Recording11 Aug 2026
- Transcript24 May 2026
- Link of Recording19 May 2026
41 earlier call documents
- Transcript15 Feb 2026
- Link of Recording10 Feb 2026
- Transcript13 Nov 2025
- Link of Recording6 Nov 2025
- Transcript of the 30th Annual General Meeting24 Sep 2025
- Transcript20 Aug 2025
- Link of Recording12 Aug 2025
- Transcript27 May 2025
- Link of Recording20 May 2025
- Transcript11 Feb 2025
- Link of Recording5 Feb 2025
- Transcript19 Nov 2024
- Link of Recording12 Nov 2024
- Transcript of the 29th Annual General Meeting9 Sep 2024
- Transcript17 Aug 2024
- Link of Recording9 Aug 2024
- Transcript23 May 2024
- Link of Recording17 May 2024
- Transcript14 Feb 2024
- Link of Recording9 Feb 2024
- Transcript11 Nov 2023
- Link of Recording7 Nov 2023
- Transcript of the 28th Annual General Meeting22 Aug 2023
- Transcript18 Aug 2023
- Transcript24 May 2023
- Link of Recording18 May 2023
- Transcript10 Feb 2023
- Link of Recording3 Feb 2023
- Transcript of the 1st Extra Ordinary General Meeting of the Financial Year 2022-2023of the members of the Company4 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call16 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call11 Nov 2022
- Transcript of 27th Annual General Meeting27 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call13 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call10 Aug 2022
- Transcript of the Company's Q4 FY22 post results Investors call held at 4:30 p.m. on May 20, 202226 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call20 May 2022
- Transcript of post results call10 Feb 2022
- Transcript for Q2 FY22 post results conference call held at 4:00 p.m. on October 29, 202122 Nov 2021
- Transcript of 26th AGM14 Aug 2021
- Transcript of EOGM held on June 11, 202114 Jun 2021
- Transcript of 25th Annual General Meeting2 Sep 2020
Zydus Lifesciences merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings1
- Amalgamation/Merger2 Dec 2019
Zydus Lifesciences share news and announcements
Newest first. Page 1 of 36.
Oct 2026
24 Oct · Analysts
19 Oct · Board meeting
16 Oct · General Updates
1 Oct
Sep 2026
11 Sep · Rating
11 Sep · Analysts
5 Sep
1 Sep
Aug 2026
26 Aug
25 Aug
21 Aug
17 Aug · Analysts
12 Aug · Analysts
11 Aug · Management
11 Aug · Business
11 Aug · Results
10 Aug · Analysts
4 Aug · Analysts
4 Aug · Analysts
Jul 2026
30 Jul · Analysts
29 Jul
25 Jul
20 Jul · Board meeting
14 Jul · News Verification
The exchange asked on 14 Jul 2026
10 Jul · Meeting
Jun 2026
29 Jun
26 Jun · General Updates
20 Jun · Updates
19 Jun · Updates
16 Jun
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 11 Sep 2026Credit ratingup 0.12%+0.5 pts vs Nifty 500market median 0.0% · five sessions +3.8% (+4.3 pts vs Nifty 500) · volume 0.8× usual · delivery −4.7 pts against usual · The announcement
- 11 Aug 2026Resultsup 6.43%+6.7 pts vs Nifty 500market median −0.7% · five sessions +1.1% (+1.9 pts vs Nifty 500) · volume 8.2× usual · delivery −27.6 pts against usual · The announcement
- 2 Jun 2026Buybackdown 1.18%−1.6 pts vs Nifty 500market median 0.0% · five sessions −0.3% (+0.8 pts vs Nifty 500) · volume 0.8× usual · delivery +12.2 pts against usual · The announcement
- 1 Jun 2026Buybackup 1.25%+2.2 pts vs Nifty 500market median 0.0% · five sessions +1.0% (+1.9 pts vs Nifty 500) · volume 0.8× usual · delivery −1.7 pts against usual · The announcement
- 29 May 2026Buybackdown 0.75%+0.6 pts vs Nifty 500market median 0.0% · five sessions −0.1% (+1.9 pts vs Nifty 500) · volume 2.1× usual · delivery +15.6 pts against usual · The announcement
- 20 May 2026Buybackup 2.15%+1.9 pts vs Nifty 500market median 0.0% · five sessions +5.9% (+4.2 pts vs Nifty 500) · volume 10.1× usual · delivery −22.9 pts against usual · The announcement
- 19 May 2026Resultsup 2.81%+2.5 pts vs Nifty 500market median −0.7% · five sessions +8.3% (+6.2 pts vs Nifty 500) · volume 5.5× usual · delivery −14.0 pts against usual · The announcement
- 13 May 2026Board or managers changedup 0.92%+0.6 pts vs Nifty 500market median 0.0% · five sessions +9.5% (+8.5 pts vs Nifty 500) · volume 0.9× usual · delivery +4.7 pts against usual · The announcement
- 1 Apr 2026Board or managers changeddown 0.92%−2.9 pts vs Nifty 500market median 0.0% · five sessions +2.3% (−5.5 pts vs Nifty 500) · volume 1.2× usual · delivery −8.6 pts against usual · The announcement
- 9 Feb 2026Resultsup 3.97%+2.9 pts vs Nifty 500market median −0.7% · five sessions +1.9% (+2.4 pts vs Nifty 500) · volume 3.5× usual · delivery −25.5 pts against usual · The announcement
20 earlier announcements
- 1 Feb 2026Board or managers changeddown 0.81%+1.2 pts vs Nifty 500market median 0.0% · five sessions +2.2% (+0.8 pts vs Nifty 500) · volume 0.3× usual · delivery −17.7 pts against usual · The announcement
- 6 Nov 2025Resultsdown 3.60%−2.9 pts vs Nifty 500market median −0.7% · five sessions −2.1% (−2.8 pts vs Nifty 500) · volume 3.8× usual · delivery −16.4 pts against usual · The announcement
- 5 Sep 2025Board or managers changedup 0.19%+0.1 pts vs Nifty 500market median 0.0% · five sessions +3.1% (+1.9 pts vs Nifty 500) · volume 1.7× usual · delivery −23.0 pts against usual · The announcement
- 28 Aug 2025Board or managers changeddown 0.94%+0.1 pts vs Nifty 500market median 0.0% · five sessions +2.1% (+1.6 pts vs Nifty 500) · volume 1.1× usual · delivery +11.2 pts against usual · The announcement
- 13 Aug 2025Board or managers changedup 3.45%+2.9 pts vs Nifty 500market median 0.0% · five sessions +2.9% (+0.3 pts vs Nifty 500) · volume 2.3× usual · delivery −12.0 pts against usual · The announcement
- 12 Aug 2025Resultsup 0.01%+0.3 pts vs Nifty 500market median −0.7% · five sessions +3.5% (+1.6 pts vs Nifty 500) · volume 1.1× usual · delivery −32.3 pts against usual · The announcement
- 16 Jun 2025Board or managers changeddown 0.06%−0.9 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−2.4 pts vs Nifty 500) · volume 0.7× usual · delivery +9.3 pts against usual · The announcement
- 20 May 2025Resultsdown 3.07%−1.8 pts vs Nifty 500market median −0.7% · five sessions +0.2% (0.0 pts vs Nifty 500) · volume 2.8× usual · delivery −14.3 pts against usual · The announcement
- 20 May 2025Board or managers changeddown 3.07%−1.8 pts vs Nifty 500market median 0.0% · five sessions +0.2% (0.0 pts vs Nifty 500) · volume 2.8× usual · delivery −14.3 pts against usual · The announcement
- 30 Apr 2025Board or managers changedup 0.02%+0.4 pts vs Nifty 500market median 0.0% · five sessions −0.2% (0.0 pts vs Nifty 500) · volume 0.4× usual · delivery +2.7 pts against usual · The announcement
- 10 Feb 2025Board or managers changeddown 2.97%−1.7 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−4.6 pts vs Nifty 500) · volume 0.5× usual · delivery −2.4 pts against usual · The announcement
- 31 Dec 2024Credit ratingup 1.54%+1.5 pts vs Nifty 500market median 0.0% · five sessions +0.5% (+1.1 pts vs Nifty 500) · volume 0.9× usual · delivery −8.7 pts against usual · The announcement
- 18 May 2024Dividendup 5.00%+4.6 pts vs Nifty 500market median 0.0% · five sessions +2.3% (+0.3 pts vs Nifty 500) · volume 0.0× usual · delivery +54.0 pts against usual · The announcement
- 20 Mar 2024Buybackup 0.16%+0.1 pts vs Nifty 500market median 0.0% · five sessions +3.1% (+0.6 pts vs Nifty 500) · volume 1.7× usual · delivery +10.2 pts against usual · The announcement
- 19 Mar 2024Buybackdown 2.16%−1.0 pts vs Nifty 500market median 0.0% · five sessions +2.6% (+1.8 pts vs Nifty 500) · volume 0.8× usual · delivery −4.3 pts against usual · The announcement
- 18 Mar 2024Buybackup 0.75%+0.7 pts vs Nifty 500market median 0.0% · five sessions +1.6% (+0.8 pts vs Nifty 500) · volume 1.6× usual · delivery −4.9 pts against usual · The announcement
- 27 Feb 2024Buybackup 0.03%−0.2 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−3.0 pts vs Nifty 500) · volume 0.6× usual · delivery +12.3 pts against usual · The announcement
- 13 Feb 2024Buybackup 0.13%−0.4 pts vs Nifty 500market median 0.0% · five sessions +5.9% (+3.1 pts vs Nifty 500) · volume 1.0× usual · delivery −12.6 pts against usual · The announcement
- 12 Feb 2024Buybackup 6.41%+7.8 pts vs Nifty 500market median 0.0% · five sessions +10.8% (+9.8 pts vs Nifty 500) · volume 5.6× usual · delivery −19.5 pts against usual · The announcement
- 9 Feb 2024Resultsup 0.37%+0.5 pts vs Nifty 500market median −0.7% · five sessions +9.6% (+9.3 pts vs Nifty 500) · volume 2.4× usual · delivery −23.9 pts against usual · The announcement
Zydus Lifesciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.